Immune defects and cardiovascular risk in X chromosome monosomy mosaicism mediated by loss of chromosome Y. A risk factor for SARS-CoV-2 vulnerability in elderly men?
Perez-Jurado, L. A.; Caceres, A.; Esko, T.; Gonzalez, J. R.
Show abstract
The ongoing pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID-19) has an estimated overall case fatality ratio of 1.38% (pre-vaccination), being 53% higher in males and increasing exponentially with age. Among 9578 individuals diagnosed with COVID-19 in the SCOURGE study, we found 133 cases (1.42%) with detectable clonal mosaicism for chromosome events (CME) and 226 males (5.08%) with acquired loss of chromosome Y (LOY). Individuals with clonal mosaic events (CME and/or LOY) showed a 54% increase in the risk of COVID-19 lethality. LOY is associated with transcriptomic biomarkers of immune dysfunction, pro-coagulation activity and cardiovascular risk. Interferon-induced genes involved in the initial immune response to SARS-CoV-2 are also down-regulated in LOY. Thus, CME and LOY underlie at least part of the sex-biased severity and mortality of COVID-19 in aging patients. Given its potential therapeutic and prognostic relevance, evaluation of clonal mosaicism should be implemented as biomarker of COVID-19 severity in elderly people.
Matching journals
The top 14 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- An expanded analysis framework for multivariate GWAS connects inflammatory biomarkers to functional variants and disease 93%
- A genome-wide association analysis of loss of ambulation in dystrophinopathy patients suggests multiple candidate modifiers of disease severity 93%
- BCL11A intellectual developmental disorder: defining the clinical spectrum and genotype-phenotype correlations 92%
Similar papers in this journal
Similar papers in this journal
- Shared and distinct genetic etiologies for different types of clonal hematopoiesis 92%
- Whole-Blood DNA Methylation Analysis Reveals Respiratory Environmental Traits Involved in COVID-19 Severity Following SARS-CoV-2 Infection 92%
- Clinical and immunological benefits of convalescent plasma therapy in severe COVID-19: insights from a single center open label randomised control trial 92%
Similar papers in this journal
Similar papers in this journal
- Bayesian inference associates rare KDR variants with specific phenotypes in pulmonary arterial hypertension 93%
- Augmenting clinical risk prediction of cardiovascular disease through protein and epigenetic biomarkers 92%
- Single-cell dissection of the immune response after acute myocardial infarction 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.